Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × obinutuzumab × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Non-Hodgkin 10 Lymphoma, Follicular 8 Lymphoma 7 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia, Hairy Cell 2 Leukemia 2 Burkitt Lymphoma 2 Neoplasm, Residual 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Heart Failure 1 Extensive Stage Small Cell Lung Cancer 1 Dendritic Cell Sarcoma, Interdigitating 1 Cytokine Release Syndrome 1

Interventions

zanubrutinib 7 Rituximab 7 ibrutinib 4 venetoclax 3 ixazomib 3 pirtobrutinib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Bortezomib 2 Biopsy 2 talquetamab 1 fludarabine 1 brexucabtagene autoleucel 1 acalabrutinib 1 Vincristine 1 Valganciclovir 1 Valacyclovir 1 Therapeutics 1 Thalidomide 1 Sirolimus 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Lenalidomide 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡